Dr. Stephen Joseph Candela, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 117 E Main St, Whiteville, NC 28472 Phone: 910-640-1022 Fax: 910-640-1448 |
Joseph Bryan Norris, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 701 Jefferson St, Whiteville, NC 28472 Phone: 910-641-8625 |
Craig Nathan Lippe, MD Orthopaedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 701 Jefferson St, Whiteville, NC 28472 Phone: 910-641-8625 |
Dr. Andrew Marvin Schuett, M.D. Orthopaedic Surgery Medicare: Medicare Enrolled Practice Location: 604 N Madison St, Whiteville, NC 28472 Phone: 910-642-7737 Fax: 910-642-7767 |
News Archive
The American Medical Association (AMA) today announced a new online tool designed to help physician practices prepare for billing and payment audits by insurers and federal contractors. The AMA's Practice Analysis Tools for Healthcare (AMA PATHâ„¢) puts self-auditing tools in the hands of physicians, allowing them to develop and evaluate fee schedules and billing safeguards without hiring an expensive consultant.
The Robert Wood Johnson Foundation (RWJF) today announced more than $1.85 million in grants for research that will offer unprecedented insight into how digital games can improve players' health behaviors and outcomes. With funding from RWJF's Health Games Research national program, nine research teams across the country will conduct extensive studies to discover, for example, how the popular dance pad video game Dance Dance Revolution might help Parkinson's patients reduce the risk of falling, how Wii Active might be most effectively implemented in high schools to help overweight students lose weight, how a mobile phone game with a breath interface might help smokers quit or reduce their tobacco use, or how facial recognition games might be designed to help people with autism learn to identify others' emotions.
Bayer HealthCare Pharmaceuticals announced today that an orphan drug designation has been granted by the U.S. Food and Drug Administration for ciprofloxacin dry powder inhaler for management of pulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis patients. A similar designation has already been granted by the European Medicines Agency.
Using leading-edge technology, neuroscientists at Beth Israel Deaconess Medical Center gained new insight into the brain circuitry that regulates water and food intake.
› Verified 3 days ago